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remarkable similarities in the mechanisms
elicited upon infection of cells by both
viruses, indicating that LTbR may operate
similarly against both viruses.
Identifying the underlyingmolecular and
cellular mechanisms of host response to
MCMV is not only of scientific interest
but also of medical relevance. High type I
interferon levels are deleterious in autoim-
mune diseases. Therefore, manipulation
of the LTbR pathway has been pursued
as a possible treatment. Inhibition of the
LT pathway stops the development of col-
lagenase-induced arthritis and protects
adult animals against experimental auto-
immune encephalomyelitis (EAE) (Ware,
2005). The study of Schneider et al.
(2008) indicates that regulation of the
type I IFN through LT signaling may also
represent an alternative therapeutic strat-
egy in cases of severe HCMV infection.
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Interleukin-12 (IL-12) is important in inducing Th1 responses during infection with microbial pathogens such
as the protozoan Toxoplasma gondii. In this issue ofCell Host &Microbe, Plattner and colleagues describe an
engineered Toxoplasma strain that lacks profilin, an actin-binding molecule previously implicated in Toll-like
receptor-11-dependent IL-12 induction and now shown to be important in parasite motility and host cell
invasion.The phylum Apicomplexa is composed of
unicellular eukaryotes that live as intracel-
lular parasites. Many cause acute disease
and death in humans as well as impact-
ing the livestock industry throughout the
world. However, one such apicomplexan,
Toxoplasma gondii, while extremely com-
mon (between 20% and 80% of humans
worldwide harbor the parasite), normally
causes asymptomatic infection. Yet, true
to form for an opportunistic pathogen,
Toxoplasma can cause serious trouble inhosts with an impaired immune system.
In the laboratory, Toxoplasma has be-
come a favorite model pathogen of cell
biologists and immunologists alike. Cell
biologists have come far in unraveling
the molecular machinery the parasite
uses to invade and live within the host
cell. This effort has been tremendously
helped by sequencing of the Toxoplasma
genome, and the development of a so-
phisticated toolbox of forward and re-
verse genetic techniques. ImmunologistsCell Host & Microbknow T. gondii as a prototypic Th1-in-
ducing pathogen, at the center of which
is the parasite’s ability to induce the cy-
tokine interleukin-12 (IL-12). In this issue
of Cell Host & Microbe, Plattner and
colleagues provide a striking example
of how tools of molecular biology can
be skillfully wielded to unite immunology
and cell biology, providing insight into
a parasite molecule that seems to be
prominent in the infection biology of
T. gondii (Figure 1).e 3, February 2008 ª2008 Elsevier Inc. 61
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PreviewsThe molecule in question is a Toxo-
plasma profilin-like protein designated
TgPRF. Profilins are most well known for
their function in actin filament polymeriza-
tion across eukaryotes, and they are im-
portant in cytoskeleton assembly andmy-
osin-based motility. Using a biochemical
fractionation approach, AlanSher andcol-
leagues recently identifiedTgPRFasapar-
asitemoleculewith IL-12-inducing activity
onmouse splenic dendritic cells (DC) (Yar-
ovinsky et al., 2005). In the same study,
TgPRF was found to activate DC through
mouse Toll-like receptor (TLR)-11. As
such,TgPRFwas identifiedasaprotozoan
‘‘danger’’ molecule, alerting the host in-
nate immune system to the presence of
infection. Although TLR11 was originally
characterized for its involvement in re-
sponses to uropathogenic E. coli (Zhang
et al., 2004), TgPRF was, and still is, the
only biochemically characterized ligand
of mouse TLR11. Importantly, TLR11
knockout mice have decreased IL-12
responses and increased susceptibility
during T. gondii infection. Nevertheless,
the importance of the TgPRF/TLR11 inter-
action compared to other presumed para-
site TLR ligands was uncertain because
mice deficient inMyD88, a central adaptor
in most TLR signaling, were much more
susceptible to infection thanTLR11/an-
imals. In the present study, the groups of
Sher and Dominique Soldati-Favre have
collaborated to rigorously test the impor-
tance of TgPRF by producing a parasite
whose profilin gene has been genetically
deleted. For the first time, this has now
allowed direct assessment of TgPRF in
the immune response to Toxoplasma and
the life cycle of the parasite.
Host cell invasion by Toxoplasma is well
known to depend upon parasite actin-
based motility (Dobrowolski and Sibley,
1996). The present investigators therefore
began with the assumption that straight-
forward deletion of the profilin gene by
homologous recombination would likely
be lethal for the parasite (Toxoplasma is
haploid). Accordingly, the investigators
set about engineering a conditional knock-
out of TgPRF. This elegant but technically
challenging approach was pioneered by
Soldati-Favre and coworkers several years
ago to examine the role of parasite myosin
A in invasion (Meissner et al., 2002). For the
present study, the strategy involved intro-
ducing an ectopic TgPRF gene whose
expressionwasunder thecontrol of a tetra-62 Cell Host & Microbe 3, February 2008 ª20cycline regulatable promoter, followed by
genetic deletion of the parasite’s endo-
genous profilin gene. Now expression of
TgPRF could be switched off at will by ad-
dition of anhydrotetracycline to the growth
medium or drinking water of infected mice
(Plattner et al., 2008).
As predicted, profilin-negative para-
sites were unable to complete their life cy-
cle during in vitro infection and were also
avirulent in vivo. When parasites were re-
constituted with constitutively expressed
TgPRF, in vitro infectivity and in vivo viru-
lence were restored. Invasion, which re-
quires an actin-based cytoskeleton-asso-
ciated motor called the glideosome, was
defective in the absence of TgPRF. How-
ever, profilin was dispensable for intracel-
lular growth of the parasite, a result that
is consistent with previous studies using
pharmacological ablation of actin fila-
ments. The actin-based glideosome has
been implicated in not only how parasites
enter cells but also how they exit. Toxo-
plasma egress can occur through two
mechanisms. One involves straightfor-
ward membrane rupture as the cell be-
comes overburdened with intracellular
parasites. As might be predicted, this did
not require profilin. The second method,
dubbed ‘‘induced egress,’’ requires para-
site motility. This type of egress can be
induced by calcium ionophores such as
A23817, but only, as it turns out, if the
parasites express TgPRF.
Figure 1. The Double Life of a Parasite
Profilin
A host cell infected with Toxoplasma (red) adjacent
to a cell producing IL-12 (green). Toxoplasma uses
profilin to invade cells, and host cells respond to
the same molecule through TLR11-dependent
IL-12 production.08 Elsevier Inc.It seems likely that TgPRF functions as
a true profilin, promoting actin filament
assembly and parasite motility, but some
caution is warranted with this interpreta-
tion. First, apicomplexan actin filaments
have so far proven impossible to visualize.
Evidence suggests that this is because
apicomplexans such as Toxoplasma pro-
duce only short and unstable actin fila-
ments (Sahoo et al., 2006). As a result, it
is not possible to directly examine actin
structure in the presence and absence
of TgPRF. Second, the activities of two
drugs that stabilize actin filaments (mea-
sured by appearance of pelletable actin)
are unaffected by knockout of TgPRF
(Plattner et al., 2008). Although the inves-
tigators of the present study show that
TgPRF and other apicomplexan profilins
are active in conventional actin polymeri-
zation assays, it remains to be shown
that parasite profilins display similar activ-
ity on native parasite actin molecules.
The second aspect of this study con-
cerns the profilin/TLR11 interaction and
its role in IL-12 induction. As would be
predicted based upon earlier studies (Yar-
ovinsky et al., 2005), parasites that do not
express TgPRF are defective in IL-12-in-
ducing activity on mouse splenic DC. Fur-
thermore, infection of mice with TgPRF-
negative parasites fails to elicit serum
IL-12. However, the in vivo result might
be a trivial consequence of the mutant’s
inability to generate a sustained infection.
To dissociate the cell biological from the
immunological phenotype, the authors
came up with a very clever trick: they
transfected the mutant with the PRF
gene of the related malaria parasite Plas-
modium falciparum. This fully restored
invasion and infectivity but, importantly,
failed to elicit IL-12 in cultured DC or in
mice. The result suggests that lack of
IL-12 induction in vivo by TgPRF-negative
parasites is a direct result of failure to
express TgPRF rather than being the
result of defects in invasion.
Both MyD88/ and IL-12/ animals
are unable to survive acute Toxoplasma
infection (Scanga et al., 2002). In contrast,
mice survive infection without TLR11,
although they are clearly more suscepti-
ble, as measured by cyst number in the
brain during chronic infection (Yarovinsky
et al., 2005). Given the apparent lack of
IL-12 induction in the absence of parasite
TgPRF or host TLR11, why are TLR11/
mice so resistant to infection? First, there
Cell Host & Microbe
Previewsare very possibly TLR11/TgPRF-indepen-
dent IL-12 sources not apparent in serum
or in splenic DC cultures that were em-
ployed in these studies. Indeed, evidence
indicates that T. gondii glycosylphospho-
inositols possess TLR2- and TLR4-ac-
tivating properties (Debierre-Grockiego
et al., 2007). It also seems possible that
MyD88-independent pathways leading
to IL-12 could contribute to resistance in
the absence of TLR11 (Kim et al., 2006).
Finally, why hasn’t the immunostimula-
tory property of T. gondii profilin been
selected against through evolutionary
pressure?Formanypathogen-associated
molecular patterns, the answer seems to
be that the innate immune system favors
recognition of molecules essential for
microbial survival (TLR5 recognition of
bacterial flagellin would be one example
[Smith et al., 2003]). This does not seem
to be the case for TgPRF, since expres-
sion of Plasmodium profilin enables in-
vasion, but not TLR11-dependent IL-12
induction. This raises the possibility that
optimal survival of T. gondii in the mouse
host is promoted by recognition of TgPRFNew Pieces for the
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Malaria starts with the infection of the
dium has revealed the expression pa
mained unexplored. Recently, Tarun
analysis of this intriguing parasite st
vaccines and drugs.
Malaria is a devastating disease that kills
more than one million children per year,
mainly in sub-Saharan Africa. Plasmo-
dium spp., the causative agents of ma-
laria, are parasites that are transmitted
by the bite of an infected Anopheles
mosquito. During a blood meal, mosqui-
toes injectPlasmodium sporozoites underand subsequent IL-12 induction. In this
scenario, absenceof IL-12 inductionwould
lead to uncontrolled parasite growth,
quickly leading to host and consequently
parasite demise. That would seem to be
at odds with the present study, which
shows no difference in virulence between
TgPRF-positive Toxoplasma and TgPRF-
negative parasites expressing P. falcipa-
rum profilin. However, the strain of Toxo-
plasma engineered in these studies is
a member of the type I class of parasites,
which are known for extremely high viru-
lence in mice (one parasite is sufficient to
kill the host in this species). It will be
most valuable to construct TgPRF knock-
out parasites that express Plasmodium
PRF using T. gondii strains with lower vir-
ulence. This will allow an assessment of
TgPRF IL-12-inducing activity in a situa-
tion where stable long-term infection is
the normal outcome.REFERENCES
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